trending Market Intelligence /marketintelligence/en/news-insights/trending/OQmqEhwG-yUyVqh1Ulqttw2 content esgSubNav
In This List

Cerulean exploring strategic alternatives

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Cerulean exploring strategic alternatives

Cerulean Pharma Inc.'s board is conducting a comprehensive review of strategic options to maximize shareholder value.

The review is to evaluate potential alternatives such as the sale of the company; a merger; a business combination; a strategic investment in the company; or a sale, license or disposition of its assets.

Also in the review, the board is considering certain clinical assets, the company's nanoparticle-drug conjugates platform and cash reserves.